NCT03434262 2024-05-31SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsSt. Jude Children's Research HospitalPhase 1 Completed68 enrolled
NCT00863369 2024-03-20Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin LymphomaCity of Hope Medical CenterPhase 1/2 Completed33 enrolled 14 charts
NCT04156828 2023-06-29Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular LymphomaUniversity of WashingtonPhase 1 Terminated12 enrolled
NCT00003397 2019-11-04Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's LymphomaUniversity of Maryland, BaltimorePhase 2 Completed25 enrolled
NCT00290706 2019-05-28A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's LymphomaNorthwestern UniversityPhase 1/2 Terminated32 enrolled 12 charts
NCT00072514 2017-06-29Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid MalignanciesFred Hutchinson Cancer CenterPhase 2 Completed55 enrolled 6 charts